METTL3 expression promoted radioresistance in glioma by promoting glioblastoma stem cell maintenance through m6A-mediated stabilization of SOX2, and subsequent METTL3 knockdown resulted in increased radiosensitivity [39]. The gene discussed is METTL3; the disease is central nervous system cancer.